查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1755852

2032 年大豆婴儿配方奶粉市场预测：按产品类型、配方、年龄层、通路、最终用户和地区进行的全球分析

Soy-Based Infant Formula Market Forecasts to 2032 - Global Analysis By Product Type, Form, Age Group, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球大豆婴儿配方奶粉市场预计在 2025 年达到 2.9118 亿美元，到 2032 年将达到 6.397 亿美元，预测期内的复合年增长率为 11.9%。

大豆婴儿配方奶粉是奶粉植物来源牛奶替代品，专为乳糖不耐症、牛奶蛋白过敏或偏好素食或纯素饮食的婴儿设计。该产品由分离大豆蛋白製成，并添加了必需营养素，有助于正常的生长发育。虽然营养充足，但通常建议在医生指导下使用，尤其适合有特殊饮食需求或健康状况的婴儿。

人们对纯素和素食者的兴趣日益浓厚

随着越来越多的父母选择植物来源饮食，大豆基婴儿配方奶粉的需求也随之成长。人们日益意识到纯素和素食的健康益处，这推动了市场的成长。此外，对乳製品过敏和乳糖不耐症的担忧也促使人们更加青睐大豆基替代品。监管部门对植物来源营养的支持也进一步推动了植物性营养的普及。製造商正推出创新的大豆基配方，以满足消费者的需求。因此，对无乳婴儿营养品的需求正稳定成长。

来自替代牛奶的竞争

儘管豆奶的偏好日益增长，但来自其他植物性和有机替代品的竞争仍然是一个挑战。杏仁、燕麦和米配方奶粉已成为替代品，导致消费者逐渐远离豆製品。此外，水解蛋白奶粉适用于过敏体质的婴儿，限制了豆奶配方奶粉的摄取。对豆奶配方奶粉中植物雌激素的担忧促使一些家长寻求替代品。监管部门对豆奶配方奶粉的审查也进一步增加了市场扩张的复杂性。

全球都市化和可支配收入

都市化的加速促使越来越多的双薪父母寻求便利营养的婴儿配方奶粉。可支配收入的增加使他们能够购买营养价值高的优质豆奶粉。人们对永续和道德采购的意识日益增强，正在影响消费者的购买决策。城市中心分销网络的不断扩张提高了产品的可及性。电商平台在提升全球可得性发挥关键作用。随着消费者偏好的演变，製造商有机会透过有针对性的创新来扩大市场覆盖范围。

生产成本高

由于严格的品质和安全标准，大豆基婴儿配方奶粉的生产成本高昂。采购非基因改造大豆作为婴儿营养品会增加原料成本。复杂的加工和配方要求进一步增加了生产成本。合规性和认证需要生产商进行大量投资。消费者的价格敏感度可能会限制市场的成长潜力。

COVID-19的影响

疫情扰乱了供应链，导致全球大豆基婴儿配方奶粉供应面临挑战。疫情封锁期间的恐慌性抢购和囤货行为导致了暂时的短缺。人们对健康和营养的日益关注推动了对植物来源替代品的需求。随着家长纷纷寻求线上购买配方奶粉的途径，电商销售额激增。製造商纷纷提高产能并优化通路，以应对疫情带来的挑战。疫情后，对韧性供应链策略的投资可能会持续下去。

预计奶粉市场在预测期内将占据最大份额

婴儿配方奶粉因其便利性和较长的保质期，预计将在预测期内占据最大的市场占有率。由于价格实惠且易于储存，父母更青睐婴儿配方奶粉。配方技术的进步改善了大豆基婴儿配方奶粉的口感和消化率。该细分市场受益于包括超级市场和药局在内的强大分销网络。有机和强化产品等日益增加的产品创新，正在推动其进一步普及。

预计在预测期内，医院部门的复合年增长率最高。

由于新生儿乳糖不耐症的增多，预计医院奶粉市场将在预测期内达到最高成长。小儿科建议对牛奶蛋白过敏的婴儿使用大豆替代品。医院透过早期营养计画在推广婴儿配方奶粉的采用方面发挥关键作用。医疗保健投资的增加有助于提供医学推荐的婴儿配方奶粉解决方案。医疗保健提供者与婴儿配方奶粉製造商之间的伙伴关係正在提升市场渗透率。

占比最大的地区：

在预测期内，亚太地区预计将占据最大的市场占有率，这得益于人们对植物性营养的认识不断提高。快速的都市化和不断增长的可支配收入推动了植物营养的普及率。婴儿人口的增长以及人们对乳糖不耐症的担忧推动了婴儿配方奶粉的需求。该地区强大的零售网络促进了产品的广泛分销。政府推广婴儿营养的措施也进一步推动了市场的成长。

复合年增长率最高的地区：

由于北美拥有先进的医疗基础设施，预计在预测期内的复合年增长率最高。主要婴儿配方奶粉製造商的存在正在推动技术创新和产品开发。消费者对非乳製品替代品的偏好日益增长，推动了市场扩张。对婴儿配方奶粉的监管支持正在推动大豆基婴儿配方奶粉的普及。人们对无过敏原产品的日益关注正在影响购买决策。

免费客製化服务：

订阅此报告的客户可享有以下免费自订选项之一：

  • 公司简介
    • 全面分析其他市场参与者（最多 3 家公司）
    • 主要企业的SWOT分析（最多3家公司）
  • 地理细分
    • 根据客户兴趣对主要国家市场进行估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球大豆婴儿配方奶粉市场（依产品类型）

  • 低脂大豆婴儿配方奶粉
  • 全脂大豆婴儿配方奶粉
  • 有机大豆婴儿配方奶粉
  • 非基因改造大豆婴儿配方奶粉
  • 治疗配方
  • 其他产品类型

6. 全球大豆婴儿配方奶粉市场（依配方）

  • 配方奶粉
  • RTF（即食）婴儿配方奶粉
  • 液体浓缩物

7. 全球大豆配方婴儿配方奶粉市场（依年龄层）

  • 0 - 6个月
  • 6 - 12个月
  • 12-24个月

8. 全球大豆婴儿配方奶粉市场（依通路）

  • 超级市场和大卖场
  • 医院和诊所
  • 药局/药局
  • 专卖店
  • 网路零售

9. 全球大豆婴儿配方奶粉市场（依最终用户）

  • 家
  • 幼稚园
  • 医院
  • 其他最终用户

10. 全球大豆婴儿配方奶粉市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • Abbott Laboratories
  • Danone SA
  • Nestle SA
  • Reckitt Benckiser Group plc
  • Perrigo Company plc
  • The Kraft Heinz Company
  • FrieslandCampina
  • HiPP GmbH & Co. Vertrieb KG
  • The Hain Celestial Group, Inc.
  • Else Nutrition Holdings Inc.
  • Nature's One
  • Arla Foods
  • Beingmate Baby & Child Food Co., Ltd.
  • China Feihe Limited
  • Nutribray
Product Code: SMRC29746

According to Stratistics MRC, the Global Soy-Based Infant Formula Market is accounted for $291.18 million in 2025 and is expected to reach $639.70 million by 2032 growing at a CAGR of 11.9% during the forecast period. Soy-based infant formula is a plant-based alternative to cow's milk formula, designed for infants who are lactose intolerant, allergic to cow's milk protein, or whose families prefer a vegetarian or vegan diet. Made from soy protein isolate and fortified with essential nutrients, it supports normal growth and development. While nutritionally adequate, it is typically recommended under medical guidance, especially for infants with specific dietary needs or health conditions.

Market Dynamics:

Driver:

Rising vegan & vegetarian preferences

As more parents opt for plant-based diets, the demand for soy-based infant formula is increasing. The growing awareness of health benefits associated with vegan and vegetarian diets is driving market expansion. Additionally, concerns over dairy allergies and lactose intolerance have led to a preference for soy-based alternatives. Regulatory support for plant-based nutrition is further boosting adoption. Manufacturers are responding with innovative soy-based formulations to meet consumer needs. As a result, the market is witnessing steady growth in demand for non-dairy infant nutrition solutions.

Restraint:

Competition from alternative formulas

Despite the rising preference for soy-based formulas, competition from other plant-based and organic alternatives poses a challenge. Almond, oat, and rice-based formulas are emerging as substitutes, drawing consumers away from soy options. Additionally, hydrolyzed protein formulas cater to infants with sensitivities, limiting soy-based formula adoption. Concerns over phytoestrogen content in soy formula have prompted some parents to seek alternatives. Regulatory scrutiny on soy-based formulas adds further complexity to market expansion.

Opportunity:

Global urbanization & disposable income

Rising urbanization is fueling an increase in working parents who seek convenient and nutritious infant formula solutions. Higher disposable income enables parents to afford premium soy-based formulas with enhanced nutritional profiles. Growing awareness of sustainable and ethical sourcing is influencing purchasing decisions. Expanding distribution networks in urban centers allow for greater product availability. E-commerce platforms are playing a significant role in boosting global accessibility. As consumer preferences evolve, manufacturers have an opportunity to expand market reach through targeted innovations.

Threat:

High production costs

The production of soy-based infant formula entails high costs due to strict quality and safety standards. Sourcing non-GMO soybeans for infant nutrition adds to raw material expenses. Complex processing and formulation requirements further increase manufacturing costs. Regulatory compliance and certifications demand significant investment from producers. Price sensitivity among consumers may limit market growth potential.

Covid-19 Impact

The pandemic disrupted supply chains, affecting the availability of soy-based infant formula globally. Panic-buying and stockpiling during lockdowns led to temporary shortages. Increased focus on health and nutrition heightened demand for plant-based alternatives. E-commerce sales surged as parents sought online purchasing options for formula supplies. Manufacturers adapted by enhancing production capabilities and optimizing distribution channels. The post-pandemic period is likely to see continued investment in resilient supply chain strategies.

The powdered formula segment is expected to be the largest during the forecast period

The powdered formula segment is expected to account for the largest market share during the forecast period, due to its convenience and longer shelf life. Parents prefer powdered formulas for their affordability and ease of storage. Advances in formulation technology have improved the taste and digestibility of soy-based powdered formulas. The segment benefits from strong distribution networks across supermarkets and pharmacies. Increasing product innovations with organic and fortified variants are driving further adoption.

The hospitals segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the hospitals segment is predicted to witness the highest growth rate, due to increasing cases of lactose intolerance among newborns. Pediatricians recommend soy-based alternatives for infants allergic to cow's milk protein. Hospitals play a crucial role in promoting specialized infant formulas through early nutrition programs. Rising healthcare investments support the availability of medically recommended formula solutions. Partnerships between healthcare providers and formula manufacturers are strengthening market penetration.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to growing awareness of plant-based nutrition. Rapid urbanization and increasing disposable income contribute to higher adoption rates. Expanding infant population and concerns over lactose intolerance drive demand for soy-based formulas. The region's strong retail network facilitates widespread product distribution. Government initiatives promoting infant nutrition further support market growth.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to its advanced healthcare infrastructure. The presence of leading formula manufacturers boosts innovation and product development. Rising consumer preference for non-dairy alternatives is fuelling market expansion. Regulatory support for infant nutrition encourages growth in soy-based formula adoption. Increasing awareness of allergen-free options is influencing purchasing decisions.

Key players in the market

Some of the key players profiled in the Soy-Based Infant Formula Market include Abbott Laboratories, Danone S.A., Nestle S.A., Reckitt Benckiser Group plc, Perrigo Company plc, The Kraft Heinz Company, FrieslandCampina, HiPP GmbH & Co. Vertrieb KG, The Hain Celestial Group, Inc., Else Nutrition Holdings Inc., Nature's One, Arla Foods, Beingmate Baby & Child Food Co., Ltd., China Feihe Limited, and Nutribray.

Key Developments:

In May 2025, Else Nutrition Holdings Inc. is excited to announce its expanded footprint in the U.S. retail market with the launch of its Ready-to-Drink (RTD) products in a leading grocery retail chain. Starting May 2025, Else's clean-label Kids RTD products are available in 1,000 stores nationwide.

In April 2024, Perrigo Company plc announced that Opill(R) the first-ever daily birth control pill available without a prescription in the U.S. and the Women's National Basketball Association (WNBA) have entered a multi-year partnership that focuses on building confidence, strength and health equity, all of which closely align with both organizations' core priorities.

Product Types Covered:

  • Low-Fat Soy-Based Infant Formula
  • Whole-Fat Soy-Based Infant Formula
  • Organic Soy-Based Infant Formula
  • Non-GMO Soy-Based Infant Formula
  • Therapeutic Formulas
  • Other Product Types

Forms Covered:

  • Powdered Formula
  • Ready-to-Feed Formula
  • Liquid Concentrate

Age Groups Covered:

  • Retail 0-6 Months
  • 6-12 Months
  • 12-24 Months

Distribution Channels Covered:

  • Supermarkets and Hypermarkets
  • Hospitals & Clinics
  • Pharmacies/Drug Stores
  • Specialty Stores
  • Online Retail

End Users Covered:

  • Households
  • Day-care Centers
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Soy-Based Infant Formula Market, By Product Type

  • 5.1 Introduction
  • 5.2 Low-Fat Soy-Based Infant Formula
  • 5.3 Whole-Fat Soy-Based Infant Formula
  • 5.4 Organic Soy-Based Infant Formula
  • 5.5 Non-GMO Soy-Based Infant Formula
  • 5.6 Therapeutic Formulas
  • 5.7 Other Product Types

6 Global Soy-Based Infant Formula Market, By Form

  • 6.1 Introduction
  • 6.2 Powdered Formula
  • 6.3 Ready-to-Feed Formula
  • 6.4 Liquid Concentrate

7 Global Soy-Based Infant Formula Market, By Age Group

  • 7.1 Introduction
  • 7.2 0-6 Months
  • 7.3 6-12 Months
  • 7.4 12-24 Months

8 Global Soy-Based Infant Formula Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Supermarkets and Hypermarkets
  • 8.3 Hospitals & Clinics
  • 8.4 Pharmacies/Drug Stores
  • 8.5 Specialty Stores
  • 8.6 Online Retail

9 Global Soy-Based Infant Formula Market, By End User

  • 9.1 Introduction
  • 9.2 Households
  • 9.3 Daycare Centers
  • 9.4 Hospitals
  • 9.5 Other End Users

10 Global Soy-Based Infant Formula Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Abbott Laboratories
  • 12.2 Danone S.A.
  • 12.3 Nestle S.A.
  • 12.4 Reckitt Benckiser Group plc
  • 12.5 Perrigo Company plc
  • 12.6 The Kraft Heinz Company
  • 12.7 FrieslandCampina
  • 12.8 HiPP GmbH & Co. Vertrieb KG
  • 12.9 The Hain Celestial Group, Inc.
  • 12.10 Else Nutrition Holdings Inc.
  • 12.11 Nature's One
  • 12.12 Arla Foods
  • 12.13 Beingmate Baby & Child Food Co., Ltd.
  • 12.14 China Feihe Limited
  • 12.15 Nutribray

List of Tables

  • Table 1 Global Soy-Based Infant Formula Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Soy-Based Infant Formula Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Soy-Based Infant Formula Market Outlook, By Low-Fat Soy-Based Infant Formula (2024-2032) ($MN)
  • Table 4 Global Soy-Based Infant Formula Market Outlook, By Whole-Fat Soy-Based Infant Formula (2024-2032) ($MN)
  • Table 5 Global Soy-Based Infant Formula Market Outlook, By Organic Soy-Based Infant Formula (2024-2032) ($MN)
  • Table 6 Global Soy-Based Infant Formula Market Outlook, By Non-GMO Soy-Based Infant Formula (2024-2032) ($MN)
  • Table 7 Global Soy-Based Infant Formula Market Outlook, By Therapeutic Formulas (2024-2032) ($MN)
  • Table 8 Global Soy-Based Infant Formula Market Outlook, By Other Product Types (2024-2032) ($MN)
  • Table 9 Global Soy-Based Infant Formula Market Outlook, By Form (2024-2032) ($MN)
  • Table 10 Global Soy-Based Infant Formula Market Outlook, By Powdered Formula (2024-2032) ($MN)
  • Table 11 Global Soy-Based Infant Formula Market Outlook, By Ready-to-Feed Formula (2024-2032) ($MN)
  • Table 12 Global Soy-Based Infant Formula Market Outlook, By Liquid Concentrate (2024-2032) ($MN)
  • Table 13 Global Soy-Based Infant Formula Market Outlook, By Age Group (2024-2032) ($MN)
  • Table 14 Global Soy-Based Infant Formula Market Outlook, By 0-6 Months (2024-2032) ($MN)
  • Table 15 Global Soy-Based Infant Formula Market Outlook, By 6-12 Months (2024-2032) ($MN)
  • Table 16 Global Soy-Based Infant Formula Market Outlook, By 12-24 Months (2024-2032) ($MN)
  • Table 17 Global Soy-Based Infant Formula Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 18 Global Soy-Based Infant Formula Market Outlook, By Supermarkets and Hypermarkets (2024-2032) ($MN)
  • Table 19 Global Soy-Based Infant Formula Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
  • Table 20 Global Soy-Based Infant Formula Market Outlook, By Pharmacies/Drug Stores (2024-2032) ($MN)
  • Table 21 Global Soy-Based Infant Formula Market Outlook, By Specialty Stores (2024-2032) ($MN)
  • Table 22 Global Soy-Based Infant Formula Market Outlook, By Online Retail (2024-2032) ($MN)
  • Table 23 Global Soy-Based Infant Formula Market Outlook, By End User (2024-2032) ($MN)
  • Table 24 Global Soy-Based Infant Formula Market Outlook, By Households (2024-2032) ($MN)
  • Table 25 Global Soy-Based Infant Formula Market Outlook, By Daycare Centers (2024-2032) ($MN)
  • Table 26 Global Soy-Based Infant Formula Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 27 Global Soy-Based Infant Formula Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.